These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 6435178)

  • 1. A new method for in vivo measurement of brain monoamine oxidase activity.
    Inoue O; Tominaga T; Yamasaki T; Kinemuchi H
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(3):385-95. PubMed ID: 6435178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioactive N,N-dimethylphenylethylamine: a selective radiotracer for in vivo measurement of monoamine oxidase-B activity in the brain.
    Inoue O; Tominaga T; Yamasaki T; Kinemuchi H
    J Neurochem; 1985 Jan; 44(1):210-6. PubMed ID: 3917289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
    Lamensdorf I; Youdim MB; Finberg JP
    J Neurochem; 1996 Oct; 67(4):1532-9. PubMed ID: 8858937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GABA-elevating effects of the antidepressant/antipanic drug phenelzine in brain: effects of pretreatment with tranylcypromine, (-)-deprenyl and clorgyline.
    Todd KG; Baker GB
    J Affect Disord; 1995 Dec; 35(3):125-9. PubMed ID: 8749840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of N-methylphenylethylamine and N-methylphenylethanolamine as substrates for type A and type B monoamine oxidase.
    Suzuki O; Oya M; Katsumata Y
    Biochem Pharmacol; 1980 Oct; 29(19):2663-7. PubMed ID: 6775642
    [No Abstract]   [Full Text] [Related]  

  • 6. [Possible mechanism of selective inhibition of rat liver mitochondrial monoamine oxidase by chlorgiline and deprenyl].
    Severina IS
    Biokhimiia; 1979 Feb; 44(2):195-207. PubMed ID: 435561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple forms of monoamine oxidase in developing chick brain.
    Suzuki O; Katsumata Y; Oya M; Asano M
    Dev Neurosci; 1978; 1(3-4):172-6. PubMed ID: 756381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Properties of monoamine oxidase in monkey heart.
    Katayama M; Kobayashi S; Oguchi K; Yasuhara H
    Jpn J Pharmacol; 1984 Aug; 35(4):425-31. PubMed ID: 6438377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of para-hydroxyamphetamine-induced head-twitch response by inhibition of monoamine oxidase type A in the brain.
    Tadano T; Satoh S; Satoh N; Kisara K; Arai Y; Kim SK; Kinemuchi H
    J Pharmacol Exp Ther; 1989 Jul; 250(1):254-60. PubMed ID: 2501477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain region differences and some characteristics of monoamine oxidase type A and B activities in the vervet monkey.
    Murphy DL; Redmond DE; Garrick N; Baulu J
    Neurochem Res; 1979 Feb; 4(1):53-62. PubMed ID: 109783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developmental changes in the activity and substrate specificities of mouse brain monoamine oxidase.
    Koide Y; Kobayashi K
    Neurochem Res; 1984 May; 9(5):595-606. PubMed ID: 6472564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferential localization of monoamine oxidase type A activity in neurons of the locus coeruleus and type B activity in neurons of the dorsal raphe nucleus of the rat: a detailed enzyme histochemical study.
    Arai R; Kimura H; Nagatsu I; Maeda T
    Brain Res; 1997 Jan; 745(1-2):352-6. PubMed ID: 9037433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid iodide transport is reduced by administration of monoamine oxidase A inhibitors to rats.
    Cabanillas AM; Masini-Repiso AM; Costamagna ME; Pellizas C; Coleoni AH
    J Endocrinol; 1994 Nov; 143(2):303-8. PubMed ID: 7829993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of solubilization by methylethylketone of rat liver mitochondrial monoamine oxidase on inhibition by clorgyline and deprenyl of the enzyme activity].
    Severina IS; Klimova GI; Nersisian AA
    Biokhimiia; 1981 Nov; 46(11):2043-55. PubMed ID: 6797482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of monoamine oxidase isoforms modulates nicotine withdrawal syndrome in the rat.
    Malin DH; Moon WD; Goyarzu P; Barclay E; Magallanes N; Vela AJ; Negrete AP; Mathews H; Stephens B; Mills WR
    Life Sci; 2013 Oct; 93(12-14):448-53. PubMed ID: 23988853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new metabolically trapped agent by brain monoamine oxidase: N-methyl labeled (14C) N-methylphenylethylamine (14C-MPEA).
    Osamu I
    Eur J Nucl Med; 1983; 8(9):385-8. PubMed ID: 6628439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma 5-hydroxyindoleacetic acid as an indicator of monoamine oxidase-A inhibition in rat brain and peripheral tissues.
    Celada P; Artigas F
    J Neurochem; 1993 Dec; 61(6):2191-8. PubMed ID: 7504085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a region important for human monoamine oxidase B substrate and inhibitor selectivity.
    Grimsby J; Zentner M; Shih JC
    Life Sci; 1996; 58(9):777-87. PubMed ID: 8632725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The metabolism of dopamine by both forms of monoamine oxidase in the rat brain and its inhibition by cimoxatone.
    Fowler CJ; Benedetti MS
    J Neurochem; 1983 Jun; 40(6):1534-41. PubMed ID: 6406646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoamine oxidase substrates and substrate affinity.
    Domino EF
    Schizophr Bull; 1980; 6(2):292-7. PubMed ID: 6769148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.